Literature DB >> 22358642

Functional display of proteins, mutant proteins, fragments of proteins and peptides on the surface of filamentous (bacterio) phages: A review.

H Pannekoek1, M van Meijer, H Gaardsvoll, A J van Zonneveld.   

Abstract

Cytoplasmic expression of complex eukaryotic proteins inEscherichia coli usually yields inactive protein preparations. In some cases, (part) of the biological activity can be recovered by rather inefficient denaturation-renaturation procedures. Recently, novel concepts have been developed for the expression of fully functional eukaryotic proteins inE. coli. Essential to the success of these procedures is the transport of such proteins across the inner membrane to the periplasmic space, allowing proper folding and the establishment of disulfide bonding. Subsequently, fully functional proteins can be exposed on the surface of filamentous (bacterio)phages, provided a system is employed that consists of a cloning vector (e.g. the phagemid pComb3, Barbas et al., 1991) that generates phage particles in the presence of a helper phage. The main advantage of surface display of recombinant proteins is to facilitate the screening of very large numbers of different molecules by simple selection methods ("panning"). In addition, periplasmic expression yields relatively large quantities (e.g. 1 mg l(-1) of culture) soluble protein. In this review, the principle aspects of this novel expression system based on the phagemid pComb3 will be discussed. Two examples for functional periplasmic expression of human proteins inE. coli will be presented, namely i) the antigen-binding moiety (Fab fragment) of human immunoglobulins (IgGs) and ii) the human plasminogen activator inhibitor 1, an essential regulator of the plasminogen activation system. Finally, perspectives for the application of this system to express mutant proteins, fragments of proteins and peptides are indicated.

Entities:  

Year:  1995        PMID: 22358642     DOI: 10.1007/BF00744325

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  21 in total

1.  Assembly of combinatorial antibody libraries on phage surfaces: the gene III site.

Authors:  C F Barbas; A S Kang; R A Lerner; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

2.  Random peptide libraries: a source of specific protein binding molecules.

Authors:  J J Devlin; L C Panganiban; P E Devlin
Journal:  Science       Date:  1990-07-27       Impact factor: 47.728

3.  Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.

Authors:  T Ny; M Sawdey; D Lawrence; J L Millan; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

Review 4.  Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins.

Authors:  R Huber; R W Carrell
Journal:  Biochemistry       Date:  1989-11-14       Impact factor: 3.162

5.  Escherichia coli secretion of an active chimeric antibody fragment.

Authors:  M Better; C P Chang; R R Robinson; A H Horwitz
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

Review 6.  Human plasma proteinase inhibitors.

Authors:  J Travis; G S Salvesen
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

7.  The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: localization of interaction sites and physiologic relevance.

Authors:  J Keijer; M Linders; A J van Zonneveld; H J Ehrlich; J P de Boer; H Pannekoek
Journal:  Blood       Date:  1991-07-15       Impact factor: 22.113

8.  Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator.

Authors:  J Keijer; H J Ehrlich; M Linders; K T Preissner; H Pannekoek
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

9.  Antibody-selectable filamentous fd phage vectors: affinity purification of target genes.

Authors:  S F Parmley; G P Smith
Journal:  Gene       Date:  1988-12-20       Impact factor: 3.688

10.  Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family.

Authors:  H Pannekoek; H Veerman; H Lambers; P Diergaarde; C L Verweij; A J van Zonneveld; J A van Mourik
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  1 in total

Review 1.  Miniproteins as phage display-scaffolds for clinical applications.

Authors:  Frederic Zoller; Uwe Haberkorn; Walter Mier
Journal:  Molecules       Date:  2011-03-14       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.